IP Verse

Pharmaceutical Composition For Cancer Treatment - EP3616720B1

PatentPatent Analysis

EP3616720

OSAKA UNIVERSITY
Application Number
EP19202367A
Filing Date
Mar 28, 2018
Status
Granted And Under Opposition
Jan 15, 2021
Grant Date
Feb 17, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3056564B2
EP3431105B1

Bibliography

The patent EP3616720B1 was granted to Osaka University on Feb 17, 2021 following the initial filing on Mar 28, 2018 under the application number EP19202367A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GEVERS & ORESNov 17, 2021ADMISSIBLE
GLAXOSMITHKLINENov 17, 2021ADMISSIBLE
JAMES POOLENov 17, 2021ADMISSIBLE
POHLMANNov 17, 2021ADMISSIBLE
SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBNov 17, 2021ADMISSIBLE
ABBVIENov 16, 2021ADMISSIBLE
J A KEMPNov 16, 2021ADMISSIBLE
PARK GROVENov 16, 2021ADMISSIBLE
STRAWMANNov 15, 2021ADMISSIBLE
KONIG SZYNKA TILMANN VON RENESSEOct 14, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents